Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Vincerx Pharma Inc. (VINC)

  • Technical Exchange News
  • Feb. 11, 2025, 19:31 UTC
  • 62
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

T2 Biosystems Inc. (TTOO)

  • Technical Exchange News
  • Feb. 11, 2025, 19:31 UTC
  • 61
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Processa Pharmaceuticals Inc. (PCSA)

  • Technical Exchange News
  • Feb. 11, 2025, 19:31 UTC
  • 61
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Marinus Pharmaceuticals Inc (MRNS)

  • Technical Exchange News
  • Feb. 11, 2025, 19:31 UTC
  • 60
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Bionano Genomics Inc (BNGO)

  • Technical Exchange News
  • Feb. 11, 2025, 02:53 UTC
  • 59
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Bionano Genomics Inc (BNGO)

  • Technical Exchange News
  • Feb. 10, 2025, 19:26 UTC
  • 59
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

NextCure Inc (NXTC)

  • Technical Exchange News
  • Feb. 08, 2025, 02:40 UTC
  • 62
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Indaptus Therapeutics Inc. (INDP)

  • Technical Exchange News
  • Feb. 08, 2025, 02:40 UTC
  • 63
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

NextCure Inc (NXTC)

  • Technical Exchange News
  • Feb. 07, 2025, 18:43 UTC
  • 70
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Indaptus Therapeutics Inc. (INDP)

  • Technical Exchange News
  • Feb. 07, 2025, 18:43 UTC
  • 74
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 614
  • 615
  • 616
  • 617
  • 618
  • Next

Search

News categories

  • Technical Exchange News(14390)
  • Event(6229)
  • SEC News(376044)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(229693)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin